Halozyme Therapeutics | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amarin USD 573.06M 22.34M 2025-03
Amgen USD 26.73B 195M 2025-06
Baxter International USD 7.04B 1.82B 2025-03
Cytokinetics USD 886.54M 69.51M 2025-06
DBV Technologies USD 29.15M 15.24M 2025-03
Eli Lilly USD 49.85B 8.59B 2025-06
Halozyme Therapeutics USD 1.12B 139.35M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
MannKind USD 279.03M 5.29M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06


Halozyme Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.